Good health is the key to a person’s happy life. It is quite difficult today to ensure satisfactory health due to poor ecology, not always the right way of life, as well as serious ailments (hepatitis, HIV, viral, infectious diseases, etc.). The solution to this problem is highly effective and safe drugs that allow you to extend a person’s existence and ensure a decent standard of living. Biocad is a domestic leader in the development and production of vital medicines, which is developing rapidly thanks to innovative technologies, highly qualified personnel and visionary plans for the future.
History of occurrence
This enterprise of international scale combines a research center, state-of-the-art biotechnological and pharmaceutical production, research at various levels (preclinical and clinical) that meet existing standards of our time. The organization is engaged in the development of medicines, and this process includes all the stages of creating medicines and analogues: from a molecule to a finished drug. Such a format of work is inherent only to a few enterprises in the world, and Biocad is one of them. Further, drugs are launched into mass production and become available to patients. At the same time, the plant is not engaged in their implementation, but it has a service that provides information on which pharmacy you can buy the necessary tablets (if a doctor’s prescription is required).
Currently, Biocad's offices are located in several countries: China, USA, Brazil, India, Finland and other countries. The total number of employees working in branches is 1700 people, of which about 700 are engaged in science and research. And this organization arose in 2001. It was then that the construction of the first pharmaceutical plant began. The Center for Engineering Immunology was later established (2003). This research site has transformed the company into a full-cycle enterprise: from the search for a molecule to the manufacture of a product. In 2005, the first original drug of the enterprise for the treatment of urogenital infections was created - Genferon suppositories. From this point on, the development did not stop at Biocade. Employee reviews in St. Petersburg and Moscow indicate that the organization is constantly working on new projects. The result was dozens of new medicines offered to consumers on the market.
During the existence of the company, Gazprombank, Millhouse became its owners. To date, Biocad Holding (Cyprus) remains the organization’s parent company, and the founders are Valery Egorov - owner of 50% of the shares, founder and CEO of the company Dmitry Morozov and PJSC Pharmstandard (20%).
"Biocad" has 4 work sites: an industrial complex in the village. Petrovo-Dalnee and research center in the village. Lyubuchany in the Moscow region, another similar laboratory and pharmaceutical complex in the village. Strelna, St. Petersburg.
In 2017, the plant became the leader in the supply of drugs against malignant tumors to Moscow. The key to success of the organization is the use of advanced technologies, an ultramodern technical base and qualified personnel. Reviews about the company "Biocad" indicate that it produces high quality drugs. That is why, back in 2014, the company received the national industry award "Industry", which indicates the recognition of the effectiveness of the enterprise at the state level.
Company Products
Medicines developed by pharmacists are a direct response to serious common diseases of the 21st century: cancer, HIV, hepatitis, multiple sclerosis ... In addition, the company produces generics (analogues of foreign medicines) and manufactures substances for various drugs. All Biocad products, according to the reviews of employees in St. Petersburg and Moscow, can be checked for safety and quality, according to the laws of the Russian Federation, international standards and the policies of the company itself, because the main priority of the organization is to extend and improve the quality of life of patients.
The plant’s portfolio of manufactured medicines contains about 40 products (and more than 40 projects aimed at finding drugs against hepatitis C and cancer are under development). Most of the medicines produced by the company that are presented on the Russian market today occupy leading positions.
Cancer Remedies
This disease is quite common today. As you know, a malignant tumor can occur in any human organ. And patients turn to doctors for help at different stages of the disease. The outcome of treatment depends on when the patient informed the doctor of the ailment, what examination results he had at the time of treatment, and how correct the prescribed therapy was.
According to patients, the preparations of the Biocad company are well known for consumers who are ill with cancer, because it is this enterprise that produces domestic analogues of the necessary drugs based on monoclonal antibodies. The manufacturer's spectrum includes about 20 medicines that can be ordered to patients for the treatment of malignant tumors. Some of the medicines have been allocated to the Recovery Course Group. On this list: Leukostim, Trastuzumab, Bevacizumab, Taxaks. They help in the prevention and treatment of neutropenia, cancer of the colon, ovaries, kidney, peritoneum, lung. All these drugs are prescribed in a complex of therapy as indicated by the doctor.
The most popular of this group is in the Biocade - Trastuzumab. According to doctors, this drug is widely used today in the treatment of tumors of different locations and levels. Today, it is number one in the complex of therapy for cancer of the breast, stomach with HER2 overexpression.
In addition, the company also produces other drugs and bioanalogs. They are also used during treatment for the above cancers, as well as for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, Wegener's granulomatosis, microscopic polyangiitis, bone metastases, head and neck cancer, bladder, and inhibitors produced (substances that suppress the course of physiological processes ) allow you to suspend the development of the disease. “Avegra” - “Biocada”, according to medical experts, is often included in the course of therapy for malignant tumors, as compared with drugs in this group it has a wide range of indications (colorectal cancer, breast cancer, ovary, cervix, kidney, lung, glioblastoma).
All these medicines are available at the pharmacy only with a prescription. They can be ordered directly on the company’s website online, while indicating the department of the pharmacy where it is convenient to purchase the medicine. The enterprise itself does not carry out any sales, it ensures the delivery of the drug from the place of production to the point of sale. It must be remembered that the sooner treatment begins, the higher its effectiveness.
Immunity Pills
One of the directions of the Biocad company is the production of tablet preparations aimed at the treatment of autoimmune diseases. Interferon Beta-1b, a company’s product used in multiple sclerosis. Its main substance is recombinant interferon, which has an immunomodulating effect, which contributes to the active struggle of the human body with various viruses. After its use in patients, the development of the disease slows down and the number of relapses decreases. Teberif is also used to treat multiple sclerosis. It is similar to the above.
This group also includes bioanalogs based on monoclonal bodies. In this group of biocada medications, Infliximab, according to medical industry workers, has a wide range of targeted actions. It is prescribed for rheumatoid and psoriatic arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis and others. A number of projects in this direction are currently under development.
Fighting viruses and infections
Ailments of this origin are caused by various microorganisms: bacteria, viruses, fungi and parasites, therefore, diseases of this type are divided into groups:
- viral (flu, rubella, hepatitis, HIV);
- bacterial (salmonellosis, desinteria, staphillococcal and streptococcal infections);
- fungal (aspergillosis, candidiasis);
- parasitic (malaria, toxoplasmosis) and others.
The Biocad company is a manufacturer of drugs that are included in the complex of therapy against chronic viral hepatitis B and C (Tenofovir, Algeron), HIV infection (Emtricitabine, Zilacomb), urogenital infections and respiratory diseases (" Genferon "," Genferon light suppositories "(nasal spray, nasal drops), fungal infections (" Optical ").
The company is actively developing and registering new drugs aimed at treating HIV infection. Considering the fact that therapy should be taken for life in case of infection, safety and effectiveness are the main requirements for these medicines.
Scientific research
All work on the production of drugs is carried out in existing laboratories. The company has three of them:
- innovation cluster "Lyubuchany" (Moscow region);
- innovation cluster "Neudorf" (St. Petersburg);
- Front cluster innovation cluster (St. Petersburg).
According to employee reviews, Biocad is equipped with high-tech ultramodern equipment, which makes it possible to make all stages of production productive. This process is based on computer modeling methods, with the help of which a molecule is searched, its parameters are changed and then reproduced in the laboratory.
Currently, the company is working on two large-scale projects, the essence of which is the production of medicines based on monoclonal antibodies (produced by immune cells) and work on low molecular weight compounds in order to obtain preparations of a chemical nature. All of these studies cover the full development cycle: from molecules to trials. This process is provided by more than 400 scientific employees - specialists in the field of chemistry, genetics, bioengineering and others. Many of them do not stop at the achieved level of professionalism, they are engaged in self-education, conduct research, publish scientific publications reflecting the problems of creating medicines aimed at combating common diseases.
High-tech equipment, scale of production, opportunities for the implementation of scientific discoveries - all this is accumulated in this pharmaceutical enterprise, according to the reviews of employees about the Biocad company.
Workforce - the wealth of the enterprise
The staff of the organization is quite large (more than 1,500 people). Of this number, about 700 are high-level specialists. Many of them are published in publications and are members of relevant associations. Some have an MBA degree and participate in seminars and international conferences. This is direct evidence of the high level of specialists working in the company.
Since its inception, "Biocad", according to employees in St. Petersburg and Moscow, carefully selects labor personnel. The company's management clearly understands that the development of the organization directly depends on the qualifications, professional level and personal qualities of the staff. And given the fact that in production it is necessary to work on modern equipment and conduct research, the advantage is given to people with experience in this field and personal scientific achievements. At the same time, the priority direction of the enterprise is the selection of young specialists with great potential. This is a kind of "investment" of knowledge, skills for the growth of the company in the future. Easily trained and motivated workers, according to employees, in Biokad they gain a lot of experience in the process and make an excellent career.
Each person in the workplace is unique, therefore the organization uses human resources wisely and offers good working conditions for rejected work: a 5/2 work schedule (from 09:30 to 18:00), an expanded social package, VHI with dentistry, compensation for meals and classes in the gym. For a number of positions, the company promises bonuses for good work. Specialists of a higher level are provided for participation in corporate events and teambuilding (team games). The employees' feedback on Biokada (Petrov-Dalnee) indicates that a distribution of labor personnel has been organized from the metro stations Kuntsevskaya and Krasnopresenskaya. The attractive offers of the employer are corporate training, opportunities to improve the professional level, and a friendly team. The organization requires knowledge, skills and abilities from applicants, work experience for a number of vacancies, knowledge of a foreign language (English) and others.
According to the feedback of employees, the Biocad Biotechnology Company is a great opportunity to realize your potential and provide a decent standard of living for yourself and your family.
The enterprise through the eyes of workers
The pharmaceutical organization has a huge staff. According to employee reviews, Biocad has the following characteristics:
- all technological processes are conducted on top-end equipment, which makes it possible to constantly develop and improve, all employees are highly qualified specialists from whom knowledge and experience can be learned;
- active and goal-oriented workers are always involved in interesting projects, and moreover they can "create" along with everyone.
Personnel who work selflessly, putting all their strength into the implementation of the ideas and tasks of production, achieve good success in the professional field.
The positive aspects that significantly affect the choice of the employer, in this case Biokada (according to reviews from employees from St. Petersburg and Moscow), include a "white" salary, the issuance of bonuses for the timely completion of tasks in a given volume, a full social package, the provision of a VHI policy, which includes the services of a dentist, free meals for workers, reimbursement of expenses for classes in a sports club, and the provision of corporate scooters in the summer.
It should be noted that, according to the reviews of employees about Biokad in Moscow, taking a vacant place is not particularly difficult, but it is difficult to work for a long time, since the company, offering high salaries and other advantages, requires full dedication. Therefore, unskilled personnel and loafers will not last long there - this is a fact. Moreover, many cadres have their own ambitions, which sometimes causes difficulties in communicating with colleagues. When deciding to choose this organization as an employer, you need to weigh your abilities and think: whether a person is ready to work hard and to achieve high goals or not.
Almost all the reviews of employees indicate high requirements for applicants: Biocad (Moscow) is not for the lazy. You need to work hard and hard. For dedicated artists bonuses are provided, there is the possibility of career growth. In addition, stress resistance and the ability to work in multitasking mode are required. Salary - no delays and an excellent social package.
The disadvantages include greater severity in maintaining the work regime (being late for work is a serious violation).
Thanks to good working conditions, the organization is annually recognized as an attractive employer.
Student Offers
As mentioned above, the company is interested in providing the production process with qualified personnel with great potential.According to employees about Biokad in St. Petersburg and Moscow, there are a lot of young people in the organization’s workforce. This is because the company's priority is to attract graduates to pharmaceutical activities. That is why the search and support of talented students in the field of natural sciences in the country's universities is being conducted.
- - ( ). "" , — - . , , .
Future graduates of a specialized field (undergraduate, graduate, postgraduate) are given an excellent opportunity to undergo an internship in the laboratories of this pharmaceutical enterprise and gain knowledge in genetic engineering, cell and molecular biology, as well as gain invaluable experience in the development of new drugs. Also, the enterprise is a platform for students to perform scientific work.
All reviews of the Biocade indicate that the organization is quite widely popularizing the natural sciences. The personnel policy of the enterprise states that graduates of educational institutions must clearly understand the essence and characteristics of the industry. Therefore, for students and pupils of schools with in-depth study of natural objects, systematic tours are conducted on the sites of the plant and laboratories.
All of the above actions are aimed at attracting the younger generation to the ranks of existing pharmacists.
Future plans
The main priority of the company is innovation. The company does not just produce drugs, it is looking for new ways to solve existing problems with human health. Evidence of this is the projects that Biocad is working on, positive reviews of the employer, the search for and work with young specialists, existing scholarship programs to support talented students in the company’s profile, the development of good conditions for remuneration of teachers from schools and universities residents for medical students, scale of production and focus on solving state problems (in 2017, the company won the competition of suppliers to the Russian capital against oopuholevyh preparations). Therefore, we can confidently assert that the plans for the future include assistance to the state in implementing programs aimed at combating diseases and issuing new effective drugs.
In the 21st century, there are a number of serious diseases and it is very important to have a domestic manufacturer who will keep up to date and offer the necessary medications that are safe and reliable for patients. The pharmaceutical company "Biocad" is a leading enterprise in this direction, because, meeting the demands of the state, it provides quality products that meet Russian and international standards.